Product Name :
Tedizolid
Description:
Tedizolid, also known as TR-700, DA-7157, Torezolid, is an oxazolidinone-class antibiotic. Tedizolid has been approved by FDA on June 20, 2014, for the treatment of acute bacterial Skin and skin structure infections (ABSSSI). Tedizolid exerts its bacteriostatic microbial activity through inhibition of protein synthesis by binding to the 50S ribosomal subunit of the bacteria.
CAS:
856866-72-3
Molecular Weight:
370.34
Formula:
C17H15FN6O3
Chemical Name:
(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)pyridin-3-yl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Smiles :
CN1N=NC(=N1)C1=CC=C(C=N1)C1=CC=C(C=C1F)N1C[C@H](CO)OC1=O
InChiKey:
XFALPSLJIHVRKE-GFCCVEGCSA-N
InChi :
InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Tedizolid, also known as TR-700, DA-7157, Torezolid, is an oxazolidinone-class antibiotic. Tedizolid has been approved by FDA on June 20, 2014, for the treatment of acute bacterial Skin and skin structure infections (ABSSSI).{{Firibastat} web|{Firibastat} Metabolic Enzyme/Protease|{Firibastat} Protocol|{Firibastat} Formula|{Firibastat} manufacturer|{Firibastat} Cancer} Tedizolid exerts its bacteriostatic microbial activity through inhibition of protein synthesis by binding to the 50S ribosomal subunit of the bacteria.|Product information|CAS Number: 856866-72-3|Molecular Weight: 370.34|Formula: C17H15FN6O3|Chemical Name: (5R)-3-{3-fluoro-4-[6-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)pyridin-3-yl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one|Smiles: CN1N=NC(=N1)C1=CC=C(C=N1)C1=CC=C(C=C1F)N1C[C@H](CO)OC1=O|InChiKey: XFALPSLJIHVRKE-GFCCVEGCSA-N|InChi: InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Acamprosate} MedChemExpress|{Acamprosate} Neuronal Signaling|{Acamprosate} Protocol|{Acamprosate} Description|{Acamprosate} supplier|{Acamprosate} Epigenetic Reader Domain} |Shelf Life: ≥360 days if stored properly.PMID:23626759 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|